Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canadian Nuclear Laboratories
Chalk River, Ontario, Canadacnl.ca ↗
- Ownership
- Private
- Employees
- ~3200
- Development stage
- Other
01
Overview
CNL is a leader in radiopharmaceutical research and medical isotope production, notably actinium-225 for clinical and preclinical cancer trials; research efforts have led to international standards for dose measurement and foundational advances in targeted alpha therapies
- Therapeutic areas
- Oncology
- Modalities
- RadiopharmaceuticalTargeted alpha therapyRadioisotopeAntibody
- Industry
- Academic Hospital/University/Research
02
Partnerships
Canadian National Energy AllianceCollaborations with Canadian and international universities/research institutesSMR vendorsFederal funding and broad governmental collaborations
Beyond the preview
Go deeper on Canadian Nuclear Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Canadian Nuclear Laboratories.